Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program


Section Navigation
			
			CDC Home








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				Lawrence Berkeley National Laboratory						Print
																Related Pages
										On This Page
			Special Exposure CohortAdvisory Board Work GroupTechnical DocumentsAdvisory Board and NIOSH DiscussionsPublic CommentsDocument Archive
		
(Site Profile/Docket Number 086)
Location: Berkeley, California
Also known as: Lawrence Radiation Laboratory, LBL, Radiation Laboratory
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Lawrence Berkeley National Laboratory.
Class(es) Added to the SEC
All employees of the Department of Energy, its predecessor agencies, and their contractors and subcontractors who worked at the Lawrence Berkeley National Laboratory in Berkeley, California, from August 13, 1942 through December 31, 1961, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort.
**Note:** This class was established from Petition 160Petitions Qualified for Evaluation
Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.
Petition 160 (Aug 13, 1942 to Dec 31, 1961)
	Petition 160 Information
Steps in Petition Process:
Petition Details:Date Received
December 18, 2009Date Qualified for Evaluation
December 18, 2009Summary of Information in Petition
**Location:** Berkeley, California
**Job Titles and/or Job Duties:** All employees of the Department of Energy, its predecessor agencies, and their contractors and subcontractors
**Period of Employment:** August 13, 1942 through December 31, 1961
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
December 18, 2009 [135 KB (2 pages)](August 13, 1942 through December 31, 1961)Federal Register Notice Announcing that a Lawrence Berkeley National Laboratory SEC Petition has met the Minimum Qualifications for Review and Evaluation
December 30, 2009 [40 KB (1 page)](August 13, 1942 through December 31, 1961)SEC Petition Evaluation Report
January 22, 2010 [240 KB (56 pages)](August 13, 1942 through December 31, 1961)Evaluation Report Sent to the Advisory Board
January 25, 2010
(August 13, 1942 through December 31, 1961)Petition Discussed by the Advisory Board
The petition was discussed by the Advisory Board on February 10, 2010, during its regular meeting.
**Note:** Agendas and transcripts for Board meetings will be posted on the Advisory Board and Public Meetings page as soon as they become available.Advisory Board Recommendation on SEC Petition
March 5, 2010 [32 KB (2 pages)](August 13, 1942 through December 31, 1961)HHS Letters to Congress Regarding the SEC Petition
April 5, 2010 [77 KB (10 pages)](August 13, 1942 through December 31, 1961)HHS Designation/Determination of Additional Members to the SEC
**Designation:**
April 5, 2010 [34 KB (5 pages)](August 13, 1942 through December 31, 1961)
**Note:** A “designation” means that HHS is recommending a class be added to the SEC. A “determination” means that HHS is recommending a class **not** be added to the SEC.Federal Register Notice: Designation/Determination of a Class of Employees for Addition to the Special Exposure Cohort
**Designation:**
April 28, 2010 [47 KB (2 pages)](August 13, 1942 through December 31, 1961)
**Note:** A “designation” will be published if there is a recommendation to add a class to the SEC. A “determination” will be published if there is a recommendation **not** to add a class to the SEC.Effective Date for the SEC Class
May 5, 2010
(August 13, 1942 through December 31, 1961)
**Note:** This only applies if the class is added to the SEC.Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
May 18, 2010 [47 KB (2 pages)](August 13, 1942 through December 31, 1961)
**Note:** This only applies if the class is added to the SEC.Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
May 7, 2010 [18 KB (1 page)](August 13, 1942 through December 31, 1961)
**Note:** This only applies if the class is added to the SEC.
Advisory Board Work Group on Lawrence Berkeley National Laboratory
This Work Group is responsible for reviewing the LBNL Site Profile, the SEC petition from LBNL petitioners, the NIOSH Evaluation Report of the petition, the SC&A Review of the LBNL Site Profile, considering issues raised by the Board’s contractor (SC&A) concerning the Site Profile and the petition Evaluation Report, and for assisting NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board, changes in the Site Profile as appropriate. The Work Group should strive to develop a recommendation to the Board on whether a class should be added to the SEC.
**Work Group Members:**
Paul L. Ziemer, Ph.D. (Chair)
Bradley P. Clawson
Arthur Frank, M.D., Ph.D.
Meeting Information
**November 25, 2019**Teleconference Meeting of the Advisory Board’s Work Group on Lawrence Berkeley National Laboratory
Time/Location:
3:00 p.m. (Eastern Time)
                    Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537
                    Participant Code: 9933701
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [13 KB (1 page)]
Transcript [275 KB (56 pages)]Presentations:
NIOSH/ORAU: NIOSH Update on LBNL Efforts [355 KB (32 pages)]Discussion/Background Papers:
NIOSH/ORAU: Responses: Lawrence Berkeley National Laboratory Dose Reconstruction Methodology [262 KB (18 pages)]
                        October 29, 2019
SC&A Draft: SC&A Evaluation of NIOSH White Paper, “Method to Assess Internal Dose Using Gross Alpha, Beta, and Gamma Bioassay and Air Sampling at the Lawrence Berkeley National Laboratory” [161 KB (19 pages)]
                        Contract No. 211-2014-58081
                        SSCA-TR-2018-SP003, Revision 0
                        April 18, 2018
**April 5, 2019**Teleconference Meeting of the Advisory Board’s Work Group on Lawrence Berkeley National Laboratory
Time/Location:
9:30 a.m. (Eastern Time)
                    Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537
                    Participant Code: 9933701
Pre-Decisional Document Policy
Agenda [32 KB (2 pages)]
Transcript [474 KB (108 pages)]Discussion/Background Papers:
SC&A Draft: SC&A Evaluation of NIOSH White Paper, “Method to Assess Internal Dose Using Gross Alpha, Beta, and Gamma Bioassay and Air Sampling at the Lawrence Berkeley National Laboratory” [161 KB (19 pages)]
                        April 18, 2018
NIOSH/DCAS Draft: Method to Assess Internal Dose Using Gross Alpha, Beta, and Gamma Bioassay and Air Sampling at the Lawrence Berkeley National Laboratory [1 MB (103 pages)]
                        September 18, 2017
**March 3, 2014–CANCELED**
            Meeting of the Advisory Board’s Work Group on Lawrence Berkeley National Laboratory
Time/Location:
10:30 a.m. Eastern Standard Time (EST)
                Meeting Type: Teleconference; Public, No Comment Period
Cincinnati Airport Marriott
                2395 Progress Dr.
                Hebron, KY 41048
                Phone: 859-586-0166
Teleconference: +1-866-659-0537
                Participant Code: 9933701
Pre-Decisional Document Policy
**February 3, 2012**
            Meeting of the Advisory Board’s Work Group on Lawrence Berkeley National Laboratory
Time/Location:
9:00 a.m. Eastern Standard Time (EST)
                Meeting Type: Teleconference; Public, No Comment Period
Cincinnati Airport Marriott
                2395 Progress Dr.
                Hebron, KY 41048
                Phone: 859-586-0166
Teleconference: +1-866-659-0537
                Participant Code: 9933701
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [13 KB (1 page)]
Transcript [341 KB (151 pages)]Pre-Decisional Document Policy
Please note that as part of the procedures and processes of the Advisory Board’s Work Groups, several kinds of pre-decisional documents may be developed. These pre-decisional documents, such as white papers, matrices, working drafts, etc., are distributed among Work Group members as research and background tools to facilitate discussion and deliberation. Although discussion during a public meeting may cover pre-decisional documents, these documents often are not further revised or finalized, and thus do not reflect the final determination or evaluation of the Advisory Board and its Work Groups. Additionally, some pre-decisional documents not otherwise posted on the website may contain sensitive information, which would require an interested party to obtain such documents by filing a Freedom of Information Act (FOIA) request with the CDC/ATSDR FOIA office at foiarequests@cdc.gov.
Technical Documents
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Site Profile
Site Profile for the Lawrence Berkeley National Laboratory [1 MB (109 pages)]
Revised May 10, 2010
**Revision Includes:** Incorporates SEC-00160 into Section 1.2. Updated boilerplate language. Incorporates guidance on the assignment of recycled uranium contaminants for intakes based on uranium bioassay results. Incorporates guidance on the assignment of plutonium mixtures for intakes based on plutonium bioassay results. Incorporates additional tritium guidance on the assignment of internal dose from stable metal tritides, and organically bound tritium. Incorporated information from historical documents captured since the last revision about X-ray equipment and exams before 1975, the addition of the LAT chest projection to the X-ray exam protocol in the 1970s, and the addition of the oblique(s) chest projection(s) to the X-ray exam protocol in the 1980s. Added Table 3-1, “Frequency of occupational chest X-ray screening”. Added all the organs to Table 3-2, the table of organ doses for all time periods, and added the organ doses from the LAT and OBL chest projections. Organ doses after 1975 are based on X-ray equipment measurements at LBNL, and decreased slightly from the previous revision as a result of using site specific entrance air kerma in air measurements. Added Table 3-3, “Skin dose guidance for various chest projections and periods”, and Table 3-4, “Skin dose (rem) from various chest projections, 1942 to present”. Incorporates formal internal and NIOSH review comments. Constitutes a total rewrite of the document.Advisory Board and NIOSH Discussions on Lawrence Berkeley National Laboratory
The Lawrence Berkeley National Laboratory (LBNL) discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and has been cleared for distribution.
SC&A Draft: SC&A’s Evaluation of ORAUT-OTIB-0049, Revision 02, “Estimating Doses for Plutonium Strongly Retained in the Lung” [1.3 MB (39 pages)]
            Contract No. 75D30119C04183
            Document No. SCA-TR-2021-PR049, Revision 0
            October 7, 2021
SC&A Draft: SC&A’S Evaluation Of ORAUT-OTIB-0088, Revision 01, “External Dose Reconstruction” [296 KB (9 pages)]
            Contract No. 75D30119C04183
            Document No. SCA-TR-2021-PR088, Revision 0
            September 3, 2021
NIOSH/DCAS: Update on Lawrence Berkeley National Laboratory Site Profile Review [498 KB (31 pages)]
            Presentation at the December 11, 2019, Meeting of the Advisory Board on Radiation and Worker Health
NIOSH/ORAU: NIOSH Update on LBNL Efforts [355 KB (32 pages)]
            Presentation at the November 25, 2019, Teleconference Meeting of the Advisory Board’s Work Group on Lawrence Berkeley National Laboratory
NIOSH/ORAU: Responses: Lawrence Berkeley National Laboratory Dose Reconstruction Methodology [262 KB (18 pages)]
            October 29, 2019
SC&A Draft: SC&A Evaluation of NIOSH White Paper, “Method to Assess Internal Dose Using Gross Alpha, Beta, and Gamma Bioassay and Air Sampling at the Lawrence Berkeley National Laboratory” [161 KB (19 pages)]
            Contract No. 211-2014-58081
            SSCA-TR-2018-SP003, Revision 0
            April 18, 2018
NIOSH/DCAS Draft: Method to Assess Internal Dose Using Gross Alpha, Beta, and Gamma Bioassay and Air Sampling at the Lawrence Berkeley National Laboratory [1 MB (103 pages)]
            September 18, 2017
SC&A Memo: NIOSH December 4, 2013, Response to SC&A Comments [238 KB (3 pages)]
            February 4, 2014
NIOSH/DCAS White Paper: NIOSH Response to SC&A Comments Concerning Part of Issue 2 Regarding the Internal Monitoring Program at the Lawrence Berkeley National Laboratory [307 KB (27 pages)]
            December 4, 2013
NIOSH/DCAS White Paper: NIOSH Evaluation of the Internal and External Monitoring Programs at the Lawrence Berkeley National Laboratory [120 KB (14 pages)]
            December 4, 2013
SC&A Draft White Paper: SC&A Review of Lawrence Berkeley National Laboratory Site Profile Matrix Issue #2, Rev. 0 [93 KB (14 pages)]
            Contract No. 200-2009-28555
            September 5, 2012
SC&A Draft White Paper: SC&A Review of Lawrence Berkeley National Laboratory Site Profile Matrix Issue #3, Rev. 0 [85 KB (5 pages)]
            Contract No. 200-2009-28555
            September 5, 2012
SC&A Draft White Paper: SC&A Review of Lawrence Berkeley National Laboratory Site Profile Matrix Issues #6, #7, and #8, Rev. 0 [120 KB (17 pages)]
            Contract No. 200-2009-28555
            September 5, 2012
SC&A Draft White Paper: SC&A Review of Lawrence Berkeley National Laboratory Site Profile Matrix Issue #9, Rev. 0 [32 KB (5 pages)]
            Contract No. 200-2009-28555
            September 5, 2012
NIOSH/DCAS: NIOSH Response to NIOSH Action Item on Issue 3 as Discussed during the Work Group Meeting on Feb. 3, 2012, on Lawrence Berkeley National Laboratory Site Profile [160 KB (2 pages)]
            May 31, 2012
SC&A Draft: Issues Matrix for the Lawrence Berkeley National Laboratory Site Profile Technical Basis Document [85 KB (17 pages)]
            January 26, 2012
SC&A Draft: Review of the NIOSH Site Profile for Lawrence Berkeley National Laboratory [1.5 MB (83 pages)]
            Contract No. 200-2009-28555
            SCA-TR-SP2010-0002
            January 22, 2010
Public Comments on Lawrence Berkeley National Laboratory Documents
How to Submit Comments
Comments on Lawrence Berkeley National Laboratory Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:
NIOSH Docket Office
    Robert A. Taft Laboratories, MS-C34
    1090 Tusculum Avenue
    Cincinnati, OH 45226
    Please include the Site Profile/Docket Number (086) on all comments.
Comments Received
At this time, no comments have been submitted.
Document Archive for Lawrence Berkeley National Laboratory
Revised April 2, 2007 [600 KB (66 pages)]
**Revision Includes:** Includes Task 5 and PID review comments which were omitted from Rev 00. Constitutes a total rewrite of document. Incorporates internal formal review comments and additional NIOSH formal review comments. Attributions and Annotations added. Incorporates internal formal review comments regarding the Attributions and Annotation section only. This revision results in an increase in assigned dose and a PER is required.
Approved August 7, 2006 [551 KB (55 pages)]
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue